Table 2 Number of gameplays, demographics, and baseline scores of participants receiving high and low doses of Lumosity

From: Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD

 

Low-Dose

High-Dose

1p-value

NCPT

   

 Mean (range) Gameplays

11.8 (0–25)

757.5 (400–1994)

NA

 N Participants

616

1330

NA

 Mean (sd) Age

45.5 (15.9)

45.5 (15.1)

0.981

 Gender (% M/F/Unknown)

43.8/48.5/7.6

38.7/54.6/6.7

0.046*

 Baseline – GI (points)

   

   Mean (sd) Raw

100.3 (13.3)

102.0 (14.0)

0.012*

   2Mean (sd) Adjusted

95.4 (11.4)

97.0 (11.9)

0.005**

BAMS-7

   

 Mean (range) Gameplays

8.9 (0–25)

816 (400–1989)

NA

 N Participants

79

191

NA

 Mean (sd) Age

43.8 (15.4)

44.3 (15.2)

0.795

 Gender (% M/F/Unknown)

41.8/54.4/3.8

36.7/60.2/3.1

0.679

 Baseline – Attention (points)

   

   Mean (sd) Raw

2.60 (0.94)

2.57 (0.84)

0.814

   2Mean (sd) Adjusted

2.69 (0.91)

2.65 (0.83)

0.798

 Baseline – Mood (points)

   

   Mean (sd) Raw

2.63 (1.03)

2.77 (0.91)

0.320

   2Mean (sd) Adjusted

2.76 (1.03)

2.89 (0.89)

0.314

  1. 1 Based on Welch’s t tests for Age and Baseline and Chi-sq tests for Gender.
  2. 2Adjusted for differences in age and gender between participants receiving high and low doses of CT.
  3. **p < 0.01, *p < 0.05.
Back to article page